Education boosts HPV vaccine willingness in women, study hopes
NCT ID NCT07521163
First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 5 times
Summary
This study tests whether a structured face-to-face education program can improve women's knowledge about cervical cancer and their attitudes toward the HPV vaccine. One hundred women aged 18-49 in Turkey will be split into two groups: one receives the education, the other gets routine care. Researchers will measure changes in knowledge and beliefs 15 days after the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Health Belief Model-Based Education
- What this could lead to
- If successful, this educational approach could be used to increase HPV vaccination rates and cervical cancer awareness in similar communities.
- What could go wrong
- This is a small, early-stage study measuring knowledge and attitudes, not actual vaccination or cancer rates. Results may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
154 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 49 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18-49 years * Applied to a Family Health Center * Parents of adolescent girls (aged 10-18 years) * Able to read and write Turkish * Voluntarily agreed to participate in the study * Provided written informed consent Exclusion Criteria: * Previous HPV vaccination * Diagnosis of cervical cancer * Cognitive or psychiatric disorders that interfered with communication
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tusba Training Family Health Center
Van, Van, 65100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dry swabs could simplify HPV screening
- Can pulsed radiation extend life in metastatic cervical cancer?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- How long do HPV vaccine antibodies last? a 11-Year Follow-Up aims to find out
- New antibody aims to preserve immune checkpoint while fighting cancer
- Smart speculum could bring cervical cancer screening to remote areas